NCT03064906View on ClinicalTrials.gov

Insulet Artificial Pancreas Evaluating Meal Performance and Moderate Exercise (IDE2)

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 18, 2017

Primary Completion Date

April 7, 2017

Study Completion Date

April 7, 2017

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

Insulet AP (artificial pancreas) System

Insulet AP (artificial pancreas) system, using the Omnipod® insulin management system, Dexcom G4 Share® AP System and personalized model predictive control algorithm.

Trial Locations (3)

80045

University of Colorado Denver, Denver

94305

Stanford University, Palo Alto

94598

Diablo Clinical Research, Walnut Creek

Sponsors
All Listed Sponsors
lead

Insulet Corporation

INDUSTRY

NCT03064906 - Insulet Artificial Pancreas Evaluating Meal Performance and Moderate Exercise (IDE2) | Biotech Hunter | Biotech Hunter